![](/img/cover-not-exists.png)
Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study
Cases, Aleix, Portolés, José, Calls, Jordi, Martinez-Castelao, Alberto, Munar, María Antonia, Segarra, AlfonsoVolume:
46
Language:
english
Journal:
International Urology and Nephrology
DOI:
10.1007/s11255-014-0800-4
Date:
October, 2014
File:
PDF, 390 KB
english, 2014